Alzheimer’s Research UK has a large number of different grant schemes through which you can apply for funding. All applications must fall within Alzheimer’s Research UK’s remit which covers biomedical ...

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...

Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein ...

Alzheimer's Association experts have issued a warning about one largely-unknown symptom of early-stage dementia ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

SANTA ANA, Calif. - NKGen Biotech, Inc. (NASDAQ: NKGN), a clinical-stage biotechnology company with a current market capitalization of $17 million, has received Fast Track designation from the U.S.

Sometimes a person with dementia can lose their inhibitions and may behave in ways that others find embarrassing. Sometimes a person with dementia can lose their inhibitions and may behave in ways ...

Frontotemporal dementia (FTD) can be hard to diagnose, because it is an uncommon type of dementia and does not cause memory problems at first. However, there are some ways to diagnose FTD including ...

A new Swedish study has, for the first time, shown a link between rheumatoid arthritis (RA) and cognitive decline in dementia ...

Dr. Jeff Williamson, another senior researcher on the study, noted the practical implications for older adults. “Our study shows that intensive blood pressure control is an important strategy in the ...